GLP-1 Side Effects: Can These Weight Loss Drugs Change Your Nails?
Nail changes including lifting and discoloration emerged in two-thirds of GLP-1 medication users surveyed in a study presented at the European Academy of Dermatology and Venereology’s Congress in Vienna, womenshealthmag.com reported.
Key Clinical Takeaways:
- Nearly 40 percent of study participants using GLP-1 medications reported onycholysis, where nails lift away from the nail bed.
- Nail color changes were documented in 46 percent of the GLP-1 cohort, compared to 17 percent in the control group with obesity and type 2 diabetes.
- Researchers emphasize that the study is preliminary and does not definitively establish causation between GLP-1 drugs and nail disorders.
European Congress Presentation Highlights Survey Findings
The research surveyed 575 individuals taking GLP-1 medications alongside a control group of 1,329 people diagnosed with obesity, type 2 diabetes, or both who had never used the drugs. Nearly 40 percent of the GLP-1 group stated their nails were lifting away from the nail bed, contrasted with roughly 10 percent of the control participants. Color alterations in the nail plate appeared in 46 percent of GLP-1 users versus 17 percent of non-users.
Pre-Existing Conditions May Explain Nail Abnormalities
“This is an important signal that warrants further investigation, but it does not establish that GLP-1 medications cause nail detachment or discoloration,” said Fatima Cody Stanford, an obesity medicine physician-scientist at Massachusetts General Hospital and associate professor of medicine and pediatrics at Harvard Medical School, as reported by womenshealthmag.com.
Approximately half of the GLP-1 users noted nail abnormalities before initiating drug therapy. Pre-existing health conditions and nutritional gaps, such as iron deficiency and psoriasis, accounted for a portion of the variance between the two cohorts, according to dermatologist and study coauthor Bianca Maria Piraccini. Psoriasis triggers nail discoloration and lifting, while iron deficiency causes thin, spoon-shaped nails, per data from the American Academy of Dermatology Association.
When researchers controlled for these underlying health factors, the associations between GLP-1 use and nail changes weakened. A separate analysis examining only symptoms that reportedly commenced after starting treatment found neither association reached statistical significance.
Researchers Consider How GLP-1 Drugs Affect Nails
Investigators remain uncertain about how GLP-1 receptor agonists might influence nail pathology. Appetite reduction from the medications can impair adequate intake of vital proteins, vitamins, and minerals. Rapid weight loss places systemic stress on the body, which can impact skin, hair, and nails. However, Dana Stern, a dermatologist specializing in nail health and assistant clinical professor of dermatology at Mount Sinai Medical Center, noted that nail lifting does not typically correlate with weight loss or caloric restriction. A direct pharmacological mechanism remains under consideration.
Onycholysis can stem from everyday mechanical trauma, such as cleaning beneath the nail or athletic footwear repeatedly striking toenails during exercise. Longitudinal brown bands can develop from melanocyte activation following cuticle picking or aggressive manicures. While many pigmented bands are benign, new presentations in adults require clinical evaluation by a dermatologist.
Clinical Guidance for Patients Experiencing Nail Alterations
Patients noticing nail lifting or discoloration should photograph the affected area, document the timeline, and notify their prescribing physician or a dermatologist. Experts advise against discontinuing medication independently based solely on nail symptoms. While awaiting clinical assessment, individuals should avoid nail cosmetics, aggressive filing, buffing, and cuticle manipulation. Warning signs requiring immediate medical attention include pain, swelling, warmth, pus, bleeding, rapid pigment shifts, or new brown or black lengthwise bands that necessitate evaluation to rule out nail melanoma.
Over-the-counter nail supplements lack clinical evidence for reversing onycholysis or discoloration unless an underlying nutritional deficiency is confirmed through blood work or clinical testing. Prescribers may investigate potential nutrient gaps or adjust treatment regimens if nausea or diminished appetite impedes nutritional intake.
“Patients noticing nail changes should not automatically attribute them to GLP-1 treatment or prematurely discontinue an effective drug,” Dr. Piraccini said, as reported by womenshealthmag.com.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.